Lipoprotein(a): An underrecognized cardiovascular disease risk factor in primary care
In the US, cardiovascular disease is the leading cause of death for men and women of most racial and ethnic groups. An estimated 20%–25% of people have elevated lipoprotein(a) [Lp(a)] levels; however, it is an underrecognized risk factor for atherosclerotic heart disease and calcific aortic valve disease. Lp(a) levels are genetically determined and unaffected by lifestyle modifications and statin therapy. It is recommended that Lp(a) be measured in all adults at least once for risk assessment. Primary care nurse practitioners are well positioned to perform risk stratification, provide patient education, and manage elevated Lp(a) levels.
Authors
- Susan D. Hellier (ORCID: https://orcid.org/0000-0002-1998-9766)
Publication Details
- Journal
- The Nurse Practitioner
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1097/01.npr.0000000000000499
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00